Stating that the pharmaceutical research and development is very expensive and time consuming as compared to other industrial research, Federation of Indian Chambers of Commerce and Industry (FICCI) wants a weighted deduction under section 35(2AB) for expenditure outside the approved R&D facility in the upcoming budget 2013.
"The current provisions for deduction u/s 35(2AB) are restrictive in nature, so as to cover only expenditure incidental to research carried on at the in-house R&D facility", said FICCI.
No comments:
Post a Comment